Related Experiment Video
Updated: Sep 28, 2025
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Published on: January 14, 2020
State-matched organoid models to fight pancreatic cancer
Michael Karl Melzer1, Elodie Roger2, Alexander Kleger2
1Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany; Clinic of Urology, Ulm University Hospital, Ulm, Germany.
Abstract:
As one of the deadliest cancers, pancreatic ductal adenocarcinoma (PDAC) requires sophisticated model systems to dissect disease onset, progression, and therapy resistance, as well as to personalize therapy. In recent years, patient- and pluripotent stem cell-derived organoids have become state-of-the-art systems to refine existing therapeutic strategies and deepen our knowledge of disease pathophysiology.
Insights
Sophisticated organoid models are crucial for understanding pancreatic ductal adenocarcinoma (PDAC) development and treatment resistance. These advanced systems improve therapeutic strategies and deepen insights into PDAC pathophysiology.
Area of Science:
- Oncology
- Biomedical Research
- Cancer Biology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer.
- Effective treatment strategies and personalized therapies require advanced research models.
- Understanding PDAC onset, progression, and therapy resistance is critical.
Purpose of the Study:
- To highlight the importance of sophisticated model systems for PDAC research.
- To discuss the role of patient- and stem cell-derived organoids in advancing PDAC knowledge.
- To emphasize the utility of organoids in refining therapeutic strategies.
Main Methods:
- Review and synthesis of recent advancements in PDAC modeling.
- Focus on patient-derived organoids (PDOs).
- Focus on pluripotent stem cell-derived organoids (PSCOs).
Main Results:
- Organoid models offer a state-of-the-art platform for PDAC research.
- Patient- and stem cell-derived organoids recapitulate key aspects of PDAC.
- These models facilitate the study of disease pathophysiology and drug responses.
Conclusions:
- Organoids are powerful tools for dissecting PDAC.
- They enable refinement of current therapeutic strategies.
- Organoids are essential for deepening the understanding of PDAC and personalizing treatment.
More Related Videos
07:31Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
04:49Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research
Published on: May 5, 2021